Medlab gets positive feedback on cannabinoid cancer treatment trial by Emma Castle December 2, 2020April 26, 2024 Chronic pain treatment developer Medlab Clinical has received good results from its 12-month observation study of […]
Brexit looms but the UK remains a top target for Australian cannabis companies by Martin Lane October 1, 2020April 26, 2024
Down-scheduling decision signals the need to shift gear and take the drug approval route by Martin Lane September 16, 2020April 22, 2024
Your daily dose of cannabis news: MS Australia backs Sativex bid; Medlab’s new board member; Zelira completes cap raising; MGC Pharma trading halt by Martin Lane August 6, 2020April 22, 2024
ASX-listed companies complete significant UK cannabis orders by Josie Tutty June 30, 2020April 22, 2024
